TaiMed Biologics will take part in BioHK 2025, held at the Hong Kong Convention and Exhibition Centre (HKCEC) from September 11–13, 2025.

As a publicly listed biotechnology company, TaiMed has established a strong foundation in HIV antibody innovation while expanding its CDMO services. At BioHK, TaiMed looks forward to engaging with the biopharmaceutical and investment community to discuss growth opportunities and value creation through antibody therapeutics.

TaiMed welcomes investors and partners to connect with us during the event.
 
Back to the top